{
  "meta": {
    "title": "Psychiatric_Pharmacology",
    "url": "https://brainandscalpel.vercel.app/psychiatric-pharmacology-8bd7ecdc.html",
    "scrapedAt": "2025-11-30T11:19:52.411Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Sertraline</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoxetine</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenelzine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old man is brought to the AIIMS-ED for a throbbing headache and photophobia for 5 hours. He has severe occipital pain. On asking further, he was at bar with friends, where he had red wine. The patient is on medication for psychiatry disorder, for which he's on daily medication. He is conscious and well oriented to time, place and person.<br>Temp: 98.6<br>Pulse: 94/min,<br>Respiratory rate: 18/min<br>Blood pressure: 190/130 mm-Hg<br>Deep tendon reflex: 2+<br>This patient's symptoms are most likely caused by a side effect of which of the following medications</span></p>",
      "unique_key": "DT1185676",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185676,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Given clinical scenario with throbbing occipital headache, history of consumption of red wine (which contains Tyramine) along with psychiatric drug history (anti-depressants) with high blood pressure, well oriented and normal DTR suggestive of Hypertensive crisis (cheese reaction)</li>\n<li>Hypertensive crisis precipitates when MAO inhibitors (eg. Selegeline and Phenelzine) with ingestion of foods containing tyramine (aged cheeses aka Cheese reaction), smoked meats, alcoholic beverages (red wine), dried fruits, chocolate) are taken.</li>\n<li>Tyramine stimulates the sympathetic nervous system by releasing other neurotransmitters, such as noradrenaline, from vesicles into the synaptic cleft.</li>\n<li>Sertraline &amp; Fluoxetine<strong>(Option A &amp; C)</strong> are SSRI, used as first-line treatment for major depressive disorder.\n<ul>\n<li>Patients taking SSRIs may develop serotonin syndrome, which can also present with hypertension.</li>\n<li>However, serotonin syndrome is usually characterized by altered mental state, hyperthermia, hyperreflexia (&gt;2+), none of which are seen in this patient</li>\n</ul>\n</li>\n<li>Amitriptyline<strong>(Option B)</strong>, a tricyclic antidepressant, can be used for the treatment of depression and migraine prophylaxis.</li>\n<li>Its side effects include anticholinergic effects (tachycardia, flushed skin), sedation, and delirium.</li>\n<li>Furthermore, it is also associated with increased risk of developing serotonin syndrome.</li>\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Duloxetine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoxetine</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Mirtazapine</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Bupropion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old man comes to the psychiatrist because he feels depressed, has difficulty sleeping, lost interest in playing the badminton and low concentration for the past 4 months. He's known alcoholic for which he was referred to therapy. He has tried to cut down or stop more than once, but could not. There is no evidence of suicidal ideation. The physician offers to prescribe a medication for his current symptoms. Treatment with which of the following drugs should most be avoided in this patient?</span></p>",
      "unique_key": "DT1185702",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185702,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Given clinical scenario of patient with major depressive disorder (with depressed mood, sleep disturbance, anhedonia and loss of concentration for more than 2 weeks) with risk factor for seizure disorder (alcoholic/ alcoholic withdrawal) requires avoidance of Bupropion, as it increases risk of seizures.</li>\n<li>Bupropion is an atypical antidepressant used as a 2nd line treatment for major depressive disorder &amp; smoking cessation therapy.</li>\n<li>It selectively inhibits the reuptake of norepinephrine and dopamine (Dopamine &gt; NE)</li>\n<li>The most severe side effect is a reduce seizure threshold; therefore, bupropion is contraindicated in patients with other seizure risk factors (e.g., anorexia/bulimia, epilepsy, alcoholic/ alcohol withdrawal).</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202403076e2b1c5c-2636-4206-ae5b-e9da18c27476.jpg\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Duloxetine(Option A)</strong>: It is a serotonin-norepinephrine reuptake inhibitor (SNRI) used as a second-line treatment for major depressive disorder.</p>\n<ul>\n<li>Duloxetine is contraindicated with concomitant serotonergic drug use (including up to 1 weeks after discontinuation) because this combination increases the risk of serotonin syndrome.</li>\n<li>However, duloxetine is not known to increase the risk of seizures in alcoholics.</li>\n</ul>\n<p><strong>Fluoxetine(Option B):</strong></p>\n<ul>\n<li>It is a selective serotonin reuptake inhibitor (SSRI) used as a first-line treatment for major depressive disorder.</li>\n<li>SSRIs are frequently associated with sexual dysfunction (e.g., decreased libido, difficulty achieving erection, anorgasmia) and are thus not preferred in patients with pre-existing sexual impairment.</li>\n<li>It can also cause serotonin syndrome if used with serotonergic drugs (including up to 5 weeks for fluoxetine, 2 weeks for other SSRIs after discontinuation).</li>\n<li>However, it is not associated with seizure in alcoholics and could be an appropriate treatment option.</li>\n</ul>\n<p><strong>Mirtazapine(Option C):</strong></p>\n<ul>\n<li>It is an atypical antidepressant used as a second-line treatment for major depressive disorder.</li>\n<li>It increases appetite and weight gain, which may not always be desirable in bulimia patients as it can decrease drug compliance (a history of bulimia nervosa is not a contraindication to its use).</li>\n<li>It can also cause serotonin syndrome as other serotonergic drugs.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307ccaae33c-bdc3-46f1-8c1b-85fb88bd3174.jpg\">",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinuation of Venlafaxine and Administer Cyproheptadine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinuation of Venlafaxine and administer Dantrolene</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinuation of Venlafaxine and Obtain ECG</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinuation of Venlafaxine, antihypertensive, fluid replacement and provide sedatives</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman comes to the ED for the evaluation of a headache and palpitations associated with increased sweating for the last 6 hours. Patient has history of psychiatric disorder, was on citalopram for four weeks, but stopped three days ago and is now on venlafaxine. She does not smoke or drink alcohol.<br>Temperature : 102.2&deg;F<br>Pulse : 120/min<br>Blood pressure : 150/90 mm Hg.<br>On mental status examination, the patient is only oriented to person, but not to place or time. Deep tendon reflexes are 3+ bilaterally. Which of the following is the most likely cause of this patient's symptoms?</span></p>",
      "unique_key": "DT1185721",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185721,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This patient presents with <strong><u>H</u></strong>yperthermia, <strong><u>A</u></strong>utonomic hyperactivity (diaphoresis, tachycardia, hypertension), neuromuscular hyperactivity (hyper <strong><u>R</u></strong>eflexia) and <strong><u>M</u></strong>ental status changes (disorientation to place and time). <strong><u>(MNEMONIC: HARM)</u></strong></li>\n<li>These features in a patient who is taking serotonergic drugs (citalopram and venlafaxine) are diagnostic of serotonin syndrome, which is caused by increased serotonergic neurotransmission.</li>\n<li>It can be triggered by taking two serotonergic agents simultaneously or rapidly switching from one serotonergic agent to another without tapering the dose, as was the case with this patient.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202403078ed0565b-06ea-405b-a7c2-1a1d78206958.jpg\">\n<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2024030730821da5-d1cd-4554-a734-baa36680e97e.jpg\">",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">It can cause &uarr; Appetite and weight gain.</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Sedation is known side effect of this drug</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Sexual side effects like loss of libido and erectile dysfunction, even after dose reduction is indication of discontinuation of drug.</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">It can increase cholesterol and triglyceride level in blood</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You've been asked to identify mechanism of action of one of the anti-depressants, illustrated below. Which of the following is incorrect about the drug \"X\"<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2024030781b3086c-c5e7-4131-8013-1663a72553b4.jpg\"></span></p>",
      "unique_key": "DT1185743",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Mirtazapine:</strong></p>\n<p>As given picture illustration, given drug \"X\" is Mirtazapine which acts by Noradrenergic and specific serotonergic antidepressants (NaSSAs).</p>\n<ul>\n<li>It has a dual mechanism of action that increases the concentration of 5-HT and noradrenaline in the synaptic cleft to within the normal range.</li>\n<li>Selective &alpha;2-adrenergic antagonist &rarr; &uarr; serotonin and norepinephrine release</li>\n<li>5-HT2 and 5-HT3 receptor antagonists &rarr; &uarr; effect of serotonin on free 5-HT1 receptor is the likely cause of antidepressant action</li>\n<li>Mirtazapine is atypical anti-depressant which acts as 2nd line therapy for major depressive disorder, especially in patients who are underweight and/or who have insomnia.</li>\n<li>In contrast to SSRI, Mirtazapine has Minimal sexual side effects.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option A</strong> :&uarr; Appetite and weight gain: can also be a desired effect in underweight patient.</p>\n<p><strong>Option B </strong>: Sedation (due to H1 antagonism): can also be a desired effect for those with insomnia with MDD</p>\n<p><strong>Option D </strong>: It causes&uarr; Serum cholesterol and triglyceride levels in blood. Monitoring required in patient with dyslipidemia along with comorbidities. (E.g. Diabetes Mellitus).</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue Paroxetine</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch from Paroxetine to valproate</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Taper Paroxetine over 3 months</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Maintain Paroxetine for at least 1 year</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old man comes to the psychiatrist for a follow-up. He has been on Paroxetine for 8 months for a major depressive episode. He now feels much better. He gets around 7 hours of sleep nightly, and his appetite has increased. Over the past two years, he has also had two episodes of depressed mood, insomnia, low energy, and loss of appetite that lasted 6 weeks, for which he received treatment. On mental status examination, he describes his mood as \"good\" In addition to regular follow-up, which of the following is the most appropriate recommendation for this patient?</span></p>",
      "unique_key": "DT1185749",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In the given clinical scenario, the patient presents with remission of symptoms after paroxetine therapy.</li>\n<li>But Paroxetine therapy should be continued for at least 1-3 years in this patient with major depressive disorder because he has already had three major depressive episodes.</li>\n</ul>\n<p><strong>Antidepressant therapy is divided into three phases:</strong></p>\n<ul>\n<li>The acute phase refers to the initial therapy following diagnosis.</li>\n<li>In the continuation phase of treatment, patients remain on their therapeutic regimen for 4-9 months after achieving remission.</li>\n<li>Patients who have a sustained response to continuation pharmacotherapy for at least 6 months are recommended to transition to maintenance therapy if at least one of the following indications is present.\n<ul>\n<li>Three or more major depressive episodes (SIGECAPS)</li>\n<li>Severe episodes (e.g., suicidal ideation)</li>\n<li>Risk factors for recurrence (e.g., onset &le; 18-21 years)</li>\n</ul>\n</li>\n<li>The total duration of maintenance phase treatment is patient-dependent and must be reevaluated regularly; it can be lifelong. Ideally, pharmacotherapy is combined with cognitive-behavioural therapy.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Discontinue Paroxetine(Option A)</strong>:</p>\n<ul>\n<li>Antidepressants such as paroxetine should never be discontinued abruptly in patients with major depressive disorder, but rather tapered off over weeks or months to avoid antidepressant discontinuation syndrome or a relapse of depression.</li>\n<li>Moreover, this patient responded well to paroxetine therapy and has not reported side effects. Discontinuation is not recommended at this point</li>\n</ul>\n<p><strong>Switch from Paroxetine to valproate(Option B)</strong>:</p>\n<ul>\n<li>Patients with depressive symptoms should be thoroughly screened for bipolar disorder before beginning treatment and monitored for new-onset insomnia and irritability after initiating an SSRI.</li>\n<li>Paroxetine can precipitate a shift to hypomania or mania in patients with bipolar disorder. While this patient has become more active and his mood is elevated, he does not have a history of hypomania or mania and lacks characteristic symptoms (i.e., decreased need for sleep, flight of ideas, distractibility, and/or excessive involvement in risky activities).</li>\n<li>Therefore, a switch to valproic acid is unnecessary.</li>\n</ul>\n<p><strong>Taper Paroxetine over 3 months(Option C)</strong>:</p>\n<ul>\n<li>SSRIs should always be tapered off at some point.</li>\n<li>However, only three additional months is too short of a time frame for this patient with recurrent depressive episodes, and premature cessation could lead to a recurrence of depressive symptoms</li>\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Risperidone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old male complains that he feels \"flat\" and that he gets confused at times. He has been gaining weight and has lost his sex drive. As he moves his hands, you notice a slight tremor. He tells you that since he has been on medication, he is always thirsty and frequently has to urinate. Which of the following patients is on?</span></p>",
      "unique_key": "DT1185775",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Confusion, mood changes, decreased sexual interest, and weight gain are symptoms that may be unrelated to drug administration. On the other hand, psychiatric drugs are often responsible for such symptoms.</li>\n<li>Tremor and symptoms of nephrogenic diabetes insipidus are characteristic adverse effects of lithium that may occur at blood levels within the therapeutic range.</li>\n<li>Lithium is a psychiatric medication used primarily as a first-line therapy for bipolar disorder. It is also used in treatment-resistant depression to augment antidepressants</li>\n<li>It is thought to be due to inhibition of the phosphoinositol cascade.</li>\n<li>Lithium therapy has a very narrow therapeutic index; frequent monitoring is therefore required to prevent toxicity. therapeutic levels (0.4-1.2 mEq/L)</li>\n</ul>\n<p><strong>Common adverse events of lithium:</strong></p>\n<ul>\n<li>Tremor (fine hand tremor)</li>\n<li>Nausea, vomiting, diarrhoea</li>\n<li>Polyuria and polydipsia (due to nephrogenic diabetes insipidus)</li>\n<li>Weight gain</li>\n<li>Hypothyroidism</li>\n<li>Cognitive dulling / mental slowing</li>\n<li>Acne and skin issues (e.g., worsening of psoriasis)</li>\n<li>Hair thinning (alopecia)</li>\n<li>ECG changes (e.g., T-wave flattening)</li>\n<li>Chronic kidney disease (with long-term use)</li>\n<li>Teratogenicity - risk of Ebstein's anomaly (if used in 1st trimester)</li>\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefexime</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young woman recently diagnosed as schizophrenic has started on atypical anti-psychotic therapy. She occasionally has palpitations and dizziness. ECG is shown below. Which of the following drugs should be avoided?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307ee5df615-459d-41fd-9338-eb4a00d011b8.jpg\"></span></p>",
      "unique_key": "DT1185791",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185791,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Given an ECG with palpitation and a history of psychiatric drug, suggest a diagnosis of long QT syndrome. The primary finding in LQTS is a long QT interval corrected for heart rate (QTc) interval &rArr; 440 ms.</li>\n<li>Flucanazole also causes QT prolongation, so it should be avoided in this patient.</li>\n<li>Long QT syndrome (LQTS) is a congenital or acquired heart condition in which the QT interval (i.e., ventricular depolarisation and repolarisation) is prolonged.</li>\n<li>Most patients with LQTS are asymptomatic, but some present with seizures, syncope, or even life-threatening arrhythmias and sudden death.</li>\n<li>Treatment depends on the underlying cause: Beta blockers and implantable cardioverter defibrillator (ICD) insertion are commonly used for congenital LQTS, whereas treatment of the underlying cause (drug, electrolyte abnormality, etc.) is the first-line therapy for acquired LQTS.</li>\n<li>Of the currently available atypical antipsychotic drugs, ziprasidone carries the greatest risk of QT prolongation.</li>\n<li>Warfarin, cefixime and aspirin do not cause QT prolongation. <strong>(Other options ruled out).</strong></li>\n</ul>\n<p><strong>Other drugs causing LQTS are:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202403074ed764e2-0ec3-40de-9d87-5562df500b39.jpg\">",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the dose of benztropine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Valbenazine</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphenhydramine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman presents with involuntary movements of the tongue and face that started 4 days ago. She has schizophrenia that has been controlled with haloperidol for the past 3 years. Treatment with benztropine is begun. One week later, her symptoms have worsened. Next step in the treatment?</span></p>",
      "unique_key": "DT1185794",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185794,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Involuntary movements of the tongue and mouth, as seen in this patient, that manifest within months to years following the administration of dopamine-blocking agents like haloperidol, suggest the diagnosis of Tardive dyskinesia.</li>\n<li>Treatment options include benzodiazepines and botulinum toxin injection. VMAT inhibitors for moderate or severe symptoms include Valbenazine.</li>\n<li>Anticholinergic drugs (e.g., benztropine) can exacerbate symptoms, as seen in this patient.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Increase the dose of benztropine(Option A):</strong> It can exacerbate symptoms of TD and should be avoided.</p>\n<p><strong>Propranolol(Option B): </strong></p>\n<ul>\n<li>Propranolol can be used in akathasia but not for TD. Akathasia is a movement disorder that can manifest following the administration of antipsychotic medications (most often first-generation antipsychotics, such as haloperidol).</li>\n<li>However, it usually develops within the first 1-8 weeks after initiation of therapy. In addition, this condition is characterised by motor restlessness (i.e., a compelling urge to move), which can manifest with an inability to sit or stand still; it does not cause involuntary movements of the tongue and face.</li>\n<li>Moreover, this condition typically improves with benztropine therapy.</li>\n</ul>\n<p><strong>Diphenhydramine(Option D):</strong> Diphenhydramine is 1st generation antihistamine having anti-muscarinic action that can be used in place of benztropine.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509058c80ae44-277a-432c-9f7e-0845f350d56e.png\">",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinsonism</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudoparkinsonism</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Restless leg syndrome</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroleptic malignant syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man is brought to the physician by his husband because of difficulty walking over the past 7 days. He reports feeling stiffness in the legs and has difficulty standing from a seated position. During his last hospitalisation, 10 days ago, fluphenazine therapy was initiated. The patient takes short, quick steps during ambulation and has difficulty maintaining his balance while standing. What could be the diagnosis?</span></p>",
      "unique_key": "DT1185796",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Here patient presents with a drug-induced movement disorder that develops days to weeks after the initiation of dopamine-blocking agents (e.g., first-generation antipsychotics).</li>\n<li>This condition manifests with symptoms of Parkinsonism, such as limb rigidity, shuffling gait, bradykinesia, postural instability, and an unhabituated glabellar reflex, all of which are seen in this patient.</li>\n<li>Other medications associated with pseudoparkinsonism include metoclopramide and valproate.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307edc9f516-9135-4c08-8247-0effec4e43db.jpg\">",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Citalopram</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Duloxetine</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Sertraline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old man with a history of Parkinson's disease is diagnosed with clinical depression. Treatment with an antidepressant is begun. Which of the following drugs will be most effective in treating both Parkinson's disease and depression?</span></p>",
      "unique_key": "DT1185808",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185808,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Parkinson's disease is a condition caused by dopamine depletion secondary to the degeneration of the dopaminergic nigrostriatal tract, leading to an imbalance of dopamine (DA) and acetylcholine (ACh) (DA levels are too low and ACh levels are too high).</li>\n<li>Treatment is directed at restoring the balance between these two neurotransmitters by either increasing dopamine levels or blocking the effect of acetylcholine with anticholinergic agents.</li>\n<li>Therefore, an agent with strong anticholinergic side effects would help to alleviate some of the signs and symptoms of Parkinson's disease.</li>\n<li>Amitriptyline is a tricyclic antidepressant (CA) that has very strong anticholinergic properties and could help treat both conditions.</li>\n<li>In general, most of the tricyclic antidepressants (e.g., nortriptyline) have strong anticholinergic properties.</li>\n</ul>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoxetine</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Imipramine</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old man with GAD is particularly concerned about how medication might affect his sexual performance. His past medical history is significant for alcohol dependence. If long-term pharmacotherapy is indicated, which of the following is the most appropriate drug for this patient?</span></p>",
      "unique_key": "DT1185811",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185811,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This patient with generalised anxiety disorder (GAD) has been characterised by excessive, virtually daily, anxiety for more than 6 months.</li>\n<li>The anxiety and worry must cause functional impairment, must last at least 6 months, and must be associated with at least three of the following: restlessness, fatiguability, irritability, muscle tension, sleep disorders, and difficulty concentrating.</li>\n<li>Buspirone is a nonbenzodiazepine anxiolytic agent that is generally nonsedating, is not associated with tolerance or dependence, does not interact with benzodiazepine receptors or alcohol, has no abuse potential, and does not cause sexual dysfunction.</li>\n<li>Many physicians who treat patients with GAD start them on benzodiazepines (which act quickly) and then switch them to buspirone (which takes about 2 weeks to work) or, more commonly, the selective serotonin reuptake inhibitors, such as fluoxetine.</li>\n<li>In this case, benzodiazepines would be inadvisable because of his history of alcohol dependence. The most common side effects of buspirone are dizziness, some drowsiness (much less than with TCAs and benzodiazepines), fatigue, and impaired concentration.</li>\n<li>Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that is commonly used for the management of GAD and other anxiety disorders. Like buspirone, it can take several weeks before the therapeutic effect is seen in the patient.</li>\n<li>However, unlike buspirone, fluoxetine is associated with increased suicidal risk, anxiety, CNS stimulation, sexual dysfunction, and serotonin syndrome.</li>\n<li>Furthermore, because this patient is particularly concerned about sexual performance, prescribing a drug known to cause sexual dysfunction would not be advisable</li>\n</ul>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjugated estrogens</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoxetine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman generalized anxiety disorder comes to the emergency department because of persistent nausea, malaise, muscle cramps, drowsiness, and confusion. Laboratory studies show a serum sodium of 120 mEq/L, serum osmolality of 260 mOsmol/kg H2O, urine osmolality of 270 mOsmol/kg H2O, and urine sodium of 48 mEq/L. Which of the following drugs is the most likely cause of this patient's condition?</span></p>",
      "unique_key": "DT1185818",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185818,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient is presenting with signs and symptoms of the syndrome of inappropriate antidiuretic hormone secretion (SIADH).</li>\r\n<li><strong>Fluoxetine</strong>, a selective serotonin reuptake inhibitor (SSRI), is a well-documented cause of SIADH and resultant hyponatremia, especially in older adults.</li>\r\n<li>SIADH is characterized by hyponatremia, decreased serum osmolality (&lt;280 mOsmol/kg H20) with inappropriately increased urine osmolality (&gt;150 mOsmol/kg H20), urine sodium usually greater than 40 mEq/L, euvolemia, and normal thyroid and adrenal function.</li>\r\n<li>In SIADH, urine osmolarity is generally greater than serum osmolarity. The body will respond to increased water retention by decreasing aldosterone in an attempt to maintain euvolemia.</li>\r\n<li>SIADH can be caused by agents that increase ADH production and stimulate ADH release in the posterior pituitary.</li>\r\n<li>The most definitive treatment is to remove the offending agent and this may be sufficient.</li>\r\n<li>If removal of the drug is not sufficient or possible, treatment options include fluid restriction, salt administration, loop diuretics, conivaptan, tolvaptan, and demeclocycline.</li>\r\n<li>Hyponatremia should be treated slowly to prevent central pontine myelinolysis.</li>\r\n<li><strong>Buspirone</strong>: Though its serotonergic (5-HT2A agonist) activity raises theoretical concerns, there are no robust reports or evidence supporting it as a cause of SIADH when used alone. <strong>(Option B)</strong></li>\r\n<li><strong>Atenolol</strong> (a &beta;-blocker) and <strong>conjugated estrogens</strong> are not known to cause SIADH or hyponatremia.<strong> (Options A and C)</strong></li>\r\n</ul>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatotoxicity</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Intracranial haemorrhage</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Lethal arrhythmia</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory depression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old woman with a history of resistant depression is found unconscious after ingesting an unknown quantity of amitriptyline. Two hours after arrival, she dies, despite appropriate lifesaving measures. Which of the following is the most likely cause of death?</span></p>",
      "unique_key": "DT1185824",
      "question_audio": null,
      "question_video": null,
      "map_id": 1185824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Patients who overdose on tricyclic antidepressants (TADs) experience dangerous and often lethal effects. These arrhythmias may produce hypotension, shock, and death.</li>\n<li>Thus, monitoring for the cardiac consequences of these drugs is paramount in treating tricyclic overdoses.</li>\n</ul>\n<p><strong>Tricyclic Antidepressants toxicity:</strong></p>\n<ul>\n<li>Tricyclics can lead to the development of QT prolongation, cardiac arrhythmias, AV block, and bundle branch block. Tricyclics act by directly blocking the fast Na channels in cardiac myocytes.</li>\n<li>The side effects of TADs can result in cardiotoxicity, convulsions, and coma. Less serious but common side effects of the tricyclics include dry mouth, urinary retention, blurred vision, drowsiness and constipation.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>Supportive management of toxicity may include endotracheal intubation, hyperventilation (use is controversial but helps produce respiratory alkalosis), and treatment with IV sodium bicarbonate, which can treat ventricular arrhythmias that are associated with tricyclic antidepressants.</li>\n<li>Sodium bicarbonate acts by alkalinising the serum to oppose the arrhythmia induced by the tricyclics and by directly providing Na+ for the fast channels. Lidocaine has also been used for the treatment of cardiac arrhythmias. The treatment of choice for prolonged or recurrent seizures in TA toxicity is a benzodiazepine.</li>\n<li>Due to their overall toxicity, the TCAs have largely been supplanted by the selective serotonin reuptake inhibitors (SSRIs) in the treatment of major depressive disorder.</li>\n<li>However, TCAs are still used for treatment-resistant major depressive disorder as well as fibromyalgia, other pain syndromes, enuresis and obsessive compulsive disorder.</li>\n<li>When tricyclics are prescribed, they are often prescribed in smaller amounts than the typical prescription.</li>\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}